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ABSTRACT 
Cancer cachexia is a paraneoplastic syndrome associated with adverse prognosis and shortened survival. 
The defining feature of cachexia is extensive muscle atrophy leading to progressive functional 
impairments. The molecular mechanisms responsible for the rapid muscle wasting are not fully elucidated. Based 
on emerging evidence, we developed the hypothesis cachectic muscle wasting is caused by mitochondrial 
dysfunction increasing reactive oxygen species production leading to global oxidative stress. To test this 
hypothesis we utilized the well-established Lewis-Lung Carcinoma (LLC) model of cancer cachexia. The 
time-course study consisted of one, two, three and four week LLC tumor bearing mice and age-matched 
four week saline (PBS) control (Ctrl) mice. Tumors were implanted into the hind flank at 1X106 cells in 100 
µL PBS. The plantaris was weighed for wet mass then teased into small fiber bundles and permeabilized 
for the quantification of mitochondrial function. Mitochondrial dysfunction was classified by a decrease in 
the respiratory control ratio (RCR), which is the ratio of state 3 (maximal ADP stimulated respiration) to 
state 4 (oligomycin-induced leak respiration). Muscle mass progressively declined over the time-course, 
reaching significance at 4 weeks (Ctrl vs 4-week, p<0.05). Mitochondrial function was not different among 
groups, however individual a priori comparison between groups revealed that 4wk cancer animals 
exhibited marked mitochondrial dysfunction compared to all other groups (p<0.05). These data 
demonstrate that late stage cancer-induced muscle wasting is associated with significant mitochondrial 
dysfunction. 
 
 
 
  
